Skip NavigationSkip to Content

HPV genotyping agreement between paired cervical cytological sample and biopsy across lesion severity and vaccination

  1. Author:
    Chen, Shimin
    Du, Qiaoyun
    Yin,Jian
    Xu, Xiaoqian
    Chen, Wen
    Pan, Qinjing
    Zhang, Xun
    Hong, Ying
    Zhang, Wenhua
    Liu, Bin
    Cui, Jianfeng
    Hu, Shangying
    Zhao, Fanghui
  2. Author Address

    Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China., School of Public Health, Lanzhou University, Lanzhou, 730000, China., Tumor Virus RNA Biology Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA., Clinical Epidemiology and EBM Unit, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China., Department of Obstetrics and Gynecology, Drum Tower Clinical Medical Hospital, Nanjing Medical University, Nanjing, 210008, China., Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China. shangyinghu@cicams.ac.cn., Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China. zhaofangh@cicams.ac.cn.,
    1. Year: 2025
    2. Date: Jun 02
    3. Epub Date: 2025 06 02
  1. Journal: Virology Journal
    1. 22
    2. 1
    3. Pages: 176
  2. Type of Article: Article
  3. Article Number: 176
  1. Abstract:

    Cytological samples are genotyped to inform clinical management of HPV-infected women due to their accessibility. Conversely, HPV genotypes identified in biopsies are deemed directly associated with cervical lesions. Thus, investigating genotyping agreement between these two sample types and potential influence of lesion severity and vaccination status on their degree of concordance is essential for understanding their diagnostic reliability. Paired cervical cytological samples and formalin-fixed paraffin-embedded (FFPE) biopsies from 392 cervical intraepithelial neoplasia or cancer (CIN+) cases (187 CIN1, 111 CIN2, 94 CIN3+; 262 unvaccinated, 130 vaccinated) were genotyped using SPF10-DEIA-LiPA25 detection system. Strength of agreement was measured by kappa, with thresholds indicating varying levels of agreement. Overall, most HPV genotypes were more frequently detected in cytological samples, with seven genotypes showing statistical differences between sample types (HPV39, 51, 52, 53, 56, 58, 68/73). Multi-type infection was more prevalent in cytological samples (147 versus 76, PMcNemar's test< 0.001), whereas single-type infection was more common in FFPE biopsies (233 versus 296, PMcNemar's test< 0.001). Proportions of observed agreement for all genotypes detected exceeded 95% and Prevalence-And-Bias-Adjusted kappa values (range: 0.832 to 0.990) indicated "Strong" (threshold: 0.80 to 0.90) to "Almost Perfect" (threshold: above 0.90) agreement. Lesion severity and vaccination status had negligible impacts on genotyping agreement. In conclusion, HPV genotyping by cytological samples and FFPE biopsies performed equally well regardless of lesion severity and vaccination status, directly supporting reliable utility of cytological HPV genotyping for clinical decisions. However, impact of sample type needs to be considered when interpretating and utilizing multi-type and/or single-type infection for scientific research. ClinicalTrials.gov (NCT00779766). Registered on the 23th of October 2008. © 2025. The Author(s).

    See More

External Sources

  1. DOI: 10.1186/s12985-025-02791-x
  2. PMID: 40452051
  3. PMCID: PMC12128532
  4. PII : 10.1186/s12985-025-02791-x

Library Notes

  1. Fiscal Year: FY2024-2025
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel